Article
Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepression function.
British journal of cancer - 23 Feb 2004
Bhat-Nakshatri P, Campbell R A, Patel N M, Newton T R, King A J, Marshall M S, Ali S, Nakshatri H
Abstract excerpt
Oestrogen receptor alpha (ERalpha) is an oestrogen-activated transcription factor, which regulates proliferation and differentiation of mammary epithelial cells by activating or repressing gene expression. ERalpha is a critical prognostic indicator and a therapeutic target for breast cancer. Patients with tumours that express higher level of ERalpha have better prognosis than patients with tumours that are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
